Placebo effects during the waiting period for psychotherapy in patients with depression

被引:0
作者
Anne Schienle
Nina Jurinec
机构
[1] University of Graz,Department of Clinical Psychology
[2] Community Health Center,undefined
来源
Current Psychology | 2023年 / 42卷
关键词
Depression, cognitive-behavioral therapy; Waiting-list; Placebo;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with mental health problems typically have to wait for psychological therapies. This study aimed to investigate the effects of a placebo administered to patients with depression while they were waiting for cognitive-behavioral therapy. Sixty-seven patients were randomly assigned to a three-week waiting period with or without treatment with a take-home placebo for daily usage (herbal medicine to mobilize the body’s natural healing powers to be taken orally). Symptoms of depression (self-rated and clinician-rated) were assessed at the beginning and end of the waiting period. Moreover, each week the patients evaluated levels of energy, concentration, relaxation, well-being, and sleep quality. The placebo group showed a greater reduction in symptoms of depression (self-rated and clinician-rated) compared to the standard group. Moreover, placebo treatment was associated with improved overall well-being during the waiting period. In conclusion, placebo treatment can make the wait time for psychotherapy more tolerable for patients with depression.
引用
收藏
页码:32024 / 32029
页数:5
相关论文
共 89 条
[1]  
Ahola P(2017)Effects of scheduled waiting for psychotherapy in patients with major depression Journal of Nervous and Mental Disease 205 611-617
[2]  
Joensuu M(2013)A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments Canandian Journal of Psychiatry 58 376-385
[3]  
Knekt P(2021)The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta-analysis Acta Psychiatrica Scandinavica 144 288-299
[4]  
Lindfors O(2021)Psychotherapies for depression: A network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types World Psychiatry 20 283-293
[5]  
Saarinen P(2016)A take-home placebo treatment can reduce stress, anxiety, and symptoms of depression in a non-patient population Australian N Z Journal of Psychiatry 50 858-865
[6]  
Tolmunen T(2019)Prescribing placebos: An experimental examination of the role of dose, expectancies, and adherence in open-label placebo effects Annals of Behavioral Medicine 53 16-28
[7]  
Valkonen-Korhonen M(2008)New insights into the placebo and nocebo responses Neuron 59 195-206
[8]  
Jääskeläinen T(2020)Utilizing placebos to leverage effects of cognitive-behavioral therapy in patients with depression Journal of Affective Disorders 277 779-784
[9]  
Virtala E(2012)Open-label placebo for major depressive disorder: A pilot randomized controlled trial Psychotherapy and Psychosomatics 81 312-314
[10]  
Tiihonen J(2014)Antidepressants and the placebo effect Zeitschrift fur Psychologie 222 128-134